Follow
Richard Conway
Title
Cited by
Cited by
Year
2016 update of the EULAR recommendations for the management of early arthritis
B Combe, R Landewe, CI Daien, C Hua, D Aletaha, JM Álvaro-Gracia, ...
Annals of the rheumatic diseases 76 (6), 948-959, 2017
6322017
Methotrexate and lung disease in rheumatoid arthritis: a meta‐analysis of randomized controlled trials
R Conway, C Low, RJ Coughlan, MJ O'Donnell, JJ Carey
Arthritis & rheumatology 66 (4), 803-812, 2014
2632014
Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry
PM Machado, S Lawson-Tovey, A Strangfeld, EF Mateus, KL Hyrich, ...
Annals of the rheumatic diseases 81 (5), 695-709, 2022
1612022
JAK inhibitors in rheumatoid arthritis: an evidence-based review on the emerging clinical data
R Harrington, SA Al Nokhatha, R Conway
Journal of inflammation research, 519-531, 2020
1592020
Risk of liver disease in methotrexate treated patients
R Conway, JJ Carey
World Journal of Hepatology 9 (26), 1092, 2017
1482017
Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey
SE Sattui, JW Liew, K Kennedy, E Sirotich, M Putman, TT Moni, A Akpabio, ...
RMD open 7 (3), e001814, 2021
1442021
Methotrexate use and risk of lung disease in psoriasis, psoriatic arthritis, and inflammatory bowel disease: systematic literature review and meta-analysis of randomised …
R Conway, C Low, RJ Coughlan, MJ O’Donnell, JJ Carey
bmj 350, 2015
1382015
COVID-19 in people with rheumatic diseases: risks, outcomes, treatment considerations
R Grainger, AHJ Kim, R Conway, J Yazdany, PC Robinson
Nature Reviews Rheumatology 18 (4), 191-204, 2022
1322022
EULAR recommendations for the management and vaccination of people with rheumatic and musculoskeletal diseases in the context of SARS-CoV-2: the November 2021 update
RBM Landewé, FPB Kroon, A Alunno, A Najm, JWJ Bijlsma, ...
Annals of the rheumatic diseases 81 (12), 1628-1639, 2022
1252022
Methotrexate-associated pneumonitis and rheumatoid arthritis-interstitial lung disease: current concepts for the diagnosis and treatment
GE Fragoulis, E Nikiphorou, J Larsen, P Korsten, R Conway
Frontiers in medicine 6, 238, 2019
1242019
SARS–CoV‐2 infection and COVID‐19 outcomes in rheumatic diseases: a systematic literature review and meta‐analysis
R Conway, AA Grimshaw, MF Konig, M Putman, A Duarte‐García, ...
Arthritis & Rheumatology 74 (5), 766-775, 2022
1202022
Ustekinumab for the treatment of refractory giant cell arteritis
R Conway, L O'Neill, E O'Flynn, P Gallagher, GM McCarthy, CC Murphy, ...
Annals of the rheumatic diseases 75 (8), 1578-1579, 2016
1082016
Association between tumor necrosis factor inhibitors and the risk of hospitalization or death among patients with immune-mediated inflammatory disease and COVID-19
Z Izadi, EJ Brenner, SK Mahil, N Dand, ZZN Yiu, M Yates, RC Ungaro, ...
JAMA network open 4 (10), e2129639-e2129639, 2021
1042021
Risk of liver injury among methotrexate users: a meta-analysis of randomised controlled trials
R Conway, C Low, RJ Coughlan, MJ O’Donnell, JJ Carey
Seminars in arthritis and rheumatism 45 (2), 156-162, 2015
992015
Long-term outcome of an AMAU—a decade’s experience
R Conway, D O’riordan, B Silke
QJM: An International Journal of Medicine 107 (1), 43-49, 2014
942014
Methotrexate and interstitial lung disease: controversies and questions. A narrative review of the literature
GE Fragoulis, R Conway, E Nikiphorou
Rheumatology 58 (11), 1900-1906, 2019
922019
Ustekinumab for refractory giant cell arteritis: a prospective 52-week trial
R Conway, L O'Neill, P Gallagher, GM McCarthy, CC Murphy, DJ Veale, ...
Seminars in arthritis and rheumatism 48 (3), 523-528, 2018
922018
Risk of infection with methotrexate therapy in inflammatory diseases: a systematic review and meta-analysis
A Ibrahim, M Ahmed, R Conway, JJ Carey
Journal of clinical medicine 8 (1), 15, 2018
862018
Increased body mass index in ankylosing spondylitis is associated with greater burden of symptoms and poor perceptions of the benefits of exercise
L Durcan, F Wilson, R Conway, G Cunnane, FD O’SHEA
The Journal of rheumatology 39 (12), 2310-2314, 2012
842012
Leflunomide use and risk of lung disease in rheumatoid arthritis: a systematic literature review and metaanalysis of randomized controlled trials
R Conway, C Low, RJ Coughlan, MJ O’Donnell, JJ Carey
The Journal of rheumatology 43 (5), 855-860, 2016
782016
The system can't perform the operation now. Try again later.
Articles 1–20